Skip to content

About
News
Clinicians
Patients
Research

Menu

About
News
Clinicians
Patients
Research

AMD Publications

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Menu

All
Retina
Cornea
AMD
CNV
RVO
DME
ROP
Keratoconus
Dry Eye
Glaucoma

Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration

Retina

December 2020

Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration

Clinical and Experimental Ophthalmology

September 2020

Detrimental Effect of Delayed Re-treatment of Active Disease on Outcomes in Neovascular Age-Related Macular Degeneration: The RAMPS Study

Ophthalmology Retina

September 2020

Smoking status and treatment outcomes of vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration

Retina

September 2020

Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project

British Journal of Ophthalmology

August 2020

Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study

Clinical and Experimental Ophthalmology

July 2020

Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!

Journal Français d’Ophtalmologie

July 2020

Assessing the accuracy of a large observational registry of neovascular age-related macular degeneration

Retina

May 2020

Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry

Ophthalmology

March 2020

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions

American Journal of Ophthalmology

February 2020

Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 months

British Journal of Ophthalmology

September 2019

Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 Months

Ophthalmology Retina

August 2019

« Previous Page1 Page2 Page3 Page4 Page5 Page6 Next »

Email: ssi.ssr@sydney.edu.au
Phone: (+61) 421 787 808

Level 1, South Block
Sydney Eye Hospital
8 Macquarie Street
Sydney NSW 2000

Follow us

X-twitter Facebook Youtube

Quick links

Contact Us
Donate Now

Contact Us
Donate Now